Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA
Published Date:Mar 2015
Source:Emerg Infect Dis. 21(3):500-503.
Human Immunodeficiency Virus
Moxifloxacin Prophylaxis Against MDR TB, New York, New York, USA
Tuberculosis And Other Mycobacteria
Description:Contacts of persons infected with multidrug-resistant tuberculosis (MDR TB) have few prophylaxis options. Of 50 contacts of HIV- and MDR TB-positive persons who were treated with moxifloxacin, 30 completed treatment and 3 discontinued treatment because of gastrointestinal symptoms. Moxifloxacin was generally well-tolerated; further research of its efficacy against MDR TB is needed.
You May Also Like: